BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8134122)

  • 1. Down-regulation of MHC class I antigen in insulinoma cells controlled by the R1 element of the H-2 enhancer.
    Ye X; Kralli A; Ge R; Ricciardi RP; Knowles BB
    Oncogene; 1994 Apr; 9(4):1195-204. PubMed ID: 8134122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of MHC class I and beta 2-microglobulin gene expression in human neuronal cells. Factor binding to conserved cis-acting regulatory sequences correlates with expression of the genes.
    Drew PD; Lonergan M; Goldstein ME; Lampson LA; Ozato K; McFarlin DE
    J Immunol; 1993 Apr; 150(8 Pt 1):3300-10. PubMed ID: 8468472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN gamma/TNF alpha synergism in MHC class II induction: effect of nicotinamide on MHC class II expression but not on islet-cell apoptosis.
    Kim KA; Kim S; Chang I; Kim GS; Min YK; Lee MK; Kim KW; Lee MS
    Diabetologia; 2002 Mar; 45(3):385-93. PubMed ID: 11914744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timely immunization subverts the development of peripheral nonresponsiveness and suppresses tumor development in simian virus 40 tumor antigen-transgenic mice.
    Ye X; McCarrick J; Jewett L; Knowles BB
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3916-20. PubMed ID: 8171012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell type-specific regulation of major histocompatibility complex (MHC) class I gene expression in astrocytes, oligodendrocytes, and neurons.
    Massa PT; Ozato K; McFarlin DE
    Glia; 1993 Jul; 8(3):201-7. PubMed ID: 8225560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative regulation by the R2 element of the MHC class I enhancer in adenovirus-12 transformed cells correlates with high levels of COUP-TF binding.
    Liu X; Ge R; Westmoreland S; Cooney AJ; Tsai SY; Tsai MJ; Ricciardi RP
    Oncogene; 1994 Aug; 9(8):2183-90. PubMed ID: 8036004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic beta-cells.
    Pavlovic D; Chen MC; Gysemans CA; Mathieu C; Eizirik DL
    Eur Cytokine Netw; 1999 Sep; 10(3):403-12. PubMed ID: 10477397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of cell lines from somite stage mouse embryos and expression of major histocompatibility class I genes in these cells.
    Silverman T; Rein A; Orrison B; Langloss J; Bratthauer G; Miyazaki J; Ozato K
    J Immunol; 1988 Jun; 140(12):4378-87. PubMed ID: 2453581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
    Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
    J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two regions of the H-2 Dd promoter are responsive to dimethylsulfoxide in line 1 cells by a mechanism distinct from IFN-gamma.
    Cerosaletti KM; Woodward JG; Lord EM; Frelinger JG
    J Immunol; 1992 Feb; 148(4):1212-21. PubMed ID: 1737936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-alpha.
    Ohashi PS; Oehen S; Aichele P; Pircher H; Odermatt B; Herrera P; Higuchi Y; Buerki K; Hengartner H; Zinkernagel RM
    J Immunol; 1993 Jun; 150(11):5185-94. PubMed ID: 8496610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy.
    Mikysková R; Bubeník J; Vonka V; Smahel M; Indrova M; Bieblová J; Símová J; Jandlová T
    Int J Oncol; 2005 Feb; 26(2):521-7. PubMed ID: 15645139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The first exon of Ad12 E1A excluding the transactivation domain mediates differential binding of COUP-TF and NF-kappa B to the MHC class I enhancer in transformed cells.
    Kushner DB; Pereira DS; Liu X; Graham FL; Ricciardi RP
    Oncogene; 1996 Jan; 12(1):143-51. PubMed ID: 8552385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular analysis of mouse major histocompatibility complex class I gene expression of tumors growing in the brain].
    Yamasaki T; Kikuchi H; Yamashita J; Kärre K; Ljunggren HG; Klein G
    No Shinkei Geka; 1989 Mar; 17(3):229-37. PubMed ID: 2505151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by woodchuck hepatitis virus of class I major histocompatibility complex presentation on hepatocytes is mediated by virus envelope pre-S2 protein and can be reversed by treatment with gamma interferon.
    Wang J; Michalak TI
    J Virol; 2006 Sep; 80(17):8541-53. PubMed ID: 16912304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of TL antigen expression. Analysis of the T18d promoter region and responses to IFN-gamma.
    Wang IM; Mehta V; Cook RG
    J Immunol; 1993 Sep; 151(5):2646-57. PubMed ID: 8360484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC expression in a human adult stem cell line and its down-regulation by hCMV US gene transfection.
    Kim JY; Kim D; Choi I; Yang JS; Lee DS; Lee JR; Kang K; Kim S; Hwang WS; Lee JS; Ahn C
    Int J Biochem Cell Biol; 2005 Jan; 37(1):69-78. PubMed ID: 15381151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-fos and c-jun overexpression in malignant cells reduces their tumorigenic and metastatic potential, and affects their MHC class I gene expression.
    Yamit-Hezi A; Plaksin D; Eisenbach L
    Oncogene; 1994 Apr; 9(4):1065-79. PubMed ID: 8134110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
    Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
    Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.